Hologic, Inc. (LON:0J5Q)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 11.60B |
| Revenue (ttm) | 2.95B |
| Net Income (ttm) | 406.23M |
| Shares Out | n/a |
| EPS (ttm) | 1.76 |
| PE Ratio | 28.55 |
| Forward PE | 15.71 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 45 |
| Average Volume | 264 |
| Open | 68.10 |
| Previous Close | 68.22 |
| Day's Range | 68.10 - 69.86 |
| 52-Week Range | 51.86 - 84.33 |
| Beta | 0.63 |
| RSI | 60.52 |
| Earnings Date | Nov 3, 2025 |
About Hologic
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginos... [Read more]
Financial Performance
In 2024, Hologic's revenue was $4.03 billion, a decrease of -0.00% compared to the previous year's $4.03 billion. Earnings were $789.50 million, an increase of 73.14%.
Financial numbers in USD Financial StatementsNews
Hologic (HOLX) Nears Acquisition Deal With Blackstone and TPG
Hologic (HOLX) Nears Acquisition Deal With Blackstone and TPG
Blackstone, TPG said to be nearing over $17B deal for Hologic
Hologic (HOLX) Sees Share Surge Following Acquisition Rumors
Hologic (HOLX) Sees Share Surge Following Acquisition Rumors
Blackstone (BX) Eyes Acquisition of Hologic for Over $17B
Blackstone (BX) Eyes Acquisition of Hologic for Over $17B
Blackstone (BX) and TPG Approach Deal to Acquire Hologic
Blackstone (BX) and TPG Approach Deal to Acquire Hologic
Blackstone (BX) Approaching Deal to Acquire Hologic
Blackstone (BX) Approaching Deal to Acquire Hologic
Noteworthy Thursday Option Activity: FFIV, FICO, HOLX
Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in F5 Inc (Symbol: FFIV), where a total of 2,966 contracts have traded so far, representing approxi...
Blackstone and TPG Eye Acquisition of Hologic (HOLX) with Major Financing Efforts
Blackstone and TPG Eye Acquisition of Hologic (HOLX) with Major Financing Efforts
Hologic ticks higher amid report on financing for potential takeover
HOLX's Enhanced Fibroid Treatment Portfolio Powers GYN Surgical Growth
Hologic's GYN Surgical segment gains momentum internationally as expanded fibroid treatments support growth.
Channel Medsystems Appoints Healthcare Executive Skip Baldino to Board of Directors
BERKELEY, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Channel Medsystems, Inc., a privately held company dedicated to advancing women's health with innovative solutions, announced today the appointment ...
Hologic Expands Panther Fusion's Menu With Diagnostic Innovation
HOLX expands its Panther Fusion platform with new GI bacterial assays, securing FDA and EU approvals to boost Diagnostics growth.
Hologic upgraded at Evercore ISI on growth turnaround
Hologic (HOLX) Upgraded to Outperform by Evercore ISI Group | HOLX Stock News
Hologic (HOLX) Upgraded to Outperform by Evercore ISI Group | HOLX Stock News
Hologic (HOLX) Shares Climb After Upgrade by Evercore ISI
Hologic (HOLX) Shares Climb After Upgrade by Evercore ISI
How to Play HOLX Stock This Breast Cancer Awareness Month?
Hologic's breast health innovations, AI breakthroughs and leadership moves signal optimism ahead despite macro headwinds.
Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2025 on Monday, November 3, 2025
MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #earnings--Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2025 on Monday, November 3, 2025.
FDA Clears Hologic's (HOLX) New Diagnostic Assays
FDA Clears Hologic's (HOLX) New Diagnostic Assays
Hologic Receives FDA Clearance and CE Mark for Automated Molecular Tests to Detect Common Causes of Infectious Gastroenteritis
MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #Bacterial--Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Panther Fus...
Hologic Bets on Endomagnetics to Fuel Interventional Breast Momentum
HOLX's Interventional Breast business hits $100M as Endomag products boost recurring revenues and margins.
Why Hologic (HOLX) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
New Survey Results Underscore the Need to #BustTheMyth About Mammograms
MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #BCAM--New Survey Results Underscore the Need to #BustTheMyth About Mammograms.
Hologic (HOLX) Entrusts Minicarm.com with Fluoroscan Insight FD Mini C-Arm Sales
Hologic (HOLX) Entrusts Minicarm.com with Fluoroscan Insight FD Mini C-Arm Sales
Hologic (HOLX) Partners to Co-Market Volition's Nu.Q Discover Service
Hologic (HOLX) Partners to Co-Market Volition's Nu.Q Discover Service
Volition Signs Co-Marketing and Services Agreement with Hologic
HENDERSON, Nev. , Sept. 29, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces that it has signed an agreement with Holog...